These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1895049)

  • 1. Screening for haemochromatosis: prevalence among Danish blood donors.
    Wiggers P; Dalhøj J; Kiaer H; Ring-Larsen H; Petersen PH; Blaabjerg O; Hørder M
    J Intern Med; 1991 Sep; 230(3):265-70. PubMed ID: 1895049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing for haemochromatosis in the diabetic clinic.
    George DK; Evans RM; Crofton RW; Gunn IR
    Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway.
    Bell H; Thordal C; Raknerud N; Hansen T; Bosnes V; Halvorsen R; Heier HE; Try K; Leivestad T; Thomassen Y
    J Hepatol; 1997 Feb; 26(2):272-9. PubMed ID: 9059946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors.
    Velati C; Piperno A; Fargion S; Colombo S; Fiorelli G
    Haematologica; 1990; 75(4):309-12. PubMed ID: 2276675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hemochromatosis: population screening based on phenotype in Brazilian blood donors.
    Barbosa KV; de Souza AF; Chebli JM; Proietti FA; Meirelles RS; de Souza JL
    J Clin Gastroenterol; 2005; 39(5):430-4. PubMed ID: 15815212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R; Romeril K; Bromhead C
    Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
    Milman N
    Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hereditary hemochromatosis in prospective blood donors.
    Benn HP; Nielsen P; Fischer R; Schwarz D; Engelhardt R; Darda C; Dittmer R; Knödler B; Gabbe EE; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():314-6. PubMed ID: 9422115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin, blood donation, iron stores and haemochromatosis.
    Worwood M; Darke C
    Transfus Med; 1993 Mar; 3(1):21-8. PubMed ID: 8038893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of haemochromatosis amongst asymptomatic Australians.
    Leggett BA; Halliday JW; Brown NN; Bryant S; Powell LW
    Br J Haematol; 1990 Apr; 74(4):525-30. PubMed ID: 2346731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.
    Adams PC
    Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hereditary hemochromatosis among healthy workers. Diagnostic value of transferrin saturation assay].
    Martínez-Vázquez C; Martínez Cadilla J; Gil M; Sopeña B; Torres J; Cordeiro E; Seijas M; de la Fuente J; Méndez MJ
    An Med Interna; 2000 Dec; 17(12):628-31. PubMed ID: 11213576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic haemochromatosis.
    Rosalki SB
    Int J Clin Pract; 2002 Oct; 56(8):609-10. PubMed ID: 12425371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for genetic haemochromatosis in a rheumatology clinic.
    Olynyk J; Hall P; Ahern M; Kwiatek R; Mackinnon M
    Aust N Z J Med; 1994 Feb; 24(1):22-5. PubMed ID: 8002853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.